Fusion Pharm, Inc. (FSPM)

    THE ULTIMATE EVOLUTION OF CONTROLLED ENVIRONMENT AGRICUTURE

                                      No Single Solution Delivers Like PharmPods

CULTIVATION CONTAINER SYSTEMS

The explosive growth in organic produce and the recent meteoric rise in popularity of the local food movement are a direct result of the nutrient depleted, pesticide laden food on America's grocery store shelves and the detrimental health issues resulting from the same.

FusionPharm's primary focus is to further develop the company's patent pending line of cultivation containers.  FusionPharm is the creator and manufacturer of these cultivation container system. They are constructed of standard ISO steel shipping containers that are repurposed for use in indoor plant cultivation.  Based on the concept of Controlled Environment Agriculture (CEA) used extensively in greenhouse cultivation for decades, the PharmPod cultivation container is evolving the arena of the Controlled Environment Agriculture (CEA) concept. 

Stackable, scalable, secure, durable and clean, these containers allows FusionPharm the ability to foster an environment in the agriculture industry that makes vertical farming economically viable through it's patent pending PharmPlex cultivation centers.   Through use of these containers, stacked in an urban warehouse, the PharmPlex maximizes the containers systems scalability and creates unprecedented efficiencies in growth, energy efficiency and space efficiency for cultivation within an urban real estate footprint. Located in the heart of cities and nearest the nation's population centers, the PharmPlex cultivation centers will produce the finest possible produce, picked fresh and ripe and transported less than 100 miles to the final destination. 

FusionPharm is piloting its first PharmPlex cultivation center in Denver, Colorado and has partnered with Circle Fresh Farms to provide the agriculture expertise and distribution network for the produce that will be produced.  Circle Fresh Farms is the largest producer of organic tomatoes, cucumbers and leafy green vegetables for Whole Foods in Colorado.  Circle Fresh Farm's produce is sold in national chains and local supermarkets under the Circle Fresh Farms® brand name. Circle Fresh Farms produce is easily recognized by its

vine-ripe, consistently superior taste, texture and appearance.

URBAN-BASED GROWING, HARVESTING AND DISTRIBUTION

Our PharmPlex cultivation center concept is simple, yet revolutionary - grow and harvest your vegetables and fruits in a faster amount of time, then distribute them over a shorter distance, as compared to traditional farming methods.

Utilizing multiple, stackable cultivation containers growing containers in an urban warehouse setting, our PharmPlex cultivation centers create unprecedented efficiencies in growth, reduced energy use and a smaller real estate footprint. Our PharmPlex centers are designed to be located within the heart of cities, nearest their population centers, to deliver the freshest and finest produce within 100 miles from where they are grown.

FusionPharm is piloting its first PharmPlex cultivation center in Denver, Colorado and has partnered with Circle Fresh Farms - whose produce is recognized for its vine-ripe, consistently superior taste, texture and appearance - to provide the agricultural expertise and distribution network for the produce that will be grown. Circle Fresh Farms is the largest producer of organic tomatoes, cucumbers and leafy green vegetables for Whole Foods in Colorado, and their produce is sold in national chains and local supermarket under that same name.

FSPM Security Details

Website: http://www.fusionpharminc.com/

Filings

http://www.otcmarkets.com/stock/FSPM/filings
 

CEO : SCOTT DITTMAN'S INTERVIEWS

1-6-14 ICANNABIS RADIO Interview with FSPM CEO Scott Dittman

9-2-13 The Stock Radio Interview (FSPM) Fusion Pharm, Inc. CEO Scott Dittman

3-27-13 SmallCapVoice Interview with Fusion Pharm, Inc. (FSPM)

UNITED STATES OF AMERICA

Before the

SECURITIES AND EXCHANGE COMMISSION

SECURITIES EXCHANGE ACT OF 1934

Release No. 72177 / May 16, 2014

The Securities and Exchange Commission (“Commission”) announced the temporary

suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the “Exchange

Act”), of trading in the securities of FusionPharm, Inc. (“FusionPharm”) of Denver, Colorado, at

9:30 a.m. EDT on May 16, 2014, and terminating at 11:59 p.m. EDT on May 30, 2014.

The Commission temporarily suspended trading in the securities of FusionPharm due to a lack of

current and accurate information about the company because of questions that have been raised

about the accuracy and adequacy of publicly disseminated information concerning, among other

things: (1) the company’s assets; (2) the company’s revenues; (3) the company’s financial

statements; (4) the company’s business transactions; and (5) the company’s current financial

condition. This order was entered pursuant to Section 12(k) of the Exchange Act.

The Commission cautions broker-dealers, shareholders, and prospective purchasers that they

should carefully consider the foregoing information along with all other currently available

information and any information subsequently issued by the company.

Further, brokers and dealers should be alert to the fact that, pursuant to Rule 15c2-11 under the

Exchange Act, at the termination of the trading suspension, no quotation may be entered unless

and until they have strictly complied with all of the provisions of the rule. If any broker or dealer

has any questions as to whether or not he has complied with the rule, he should not enter any

quotation but immediately contact the staff in the Division of Trading and Markets, Office of

Interpretation and Guidance, at (202) 551-5777. If any broker or dealer is uncertain as to what is

required by Rule 15c2-11, he should refrain from entering quotations relating to FusionPharm’s

securities until such time as he has familiarized himself with the rule and is certain that all of its

provisions have been met. If any broker or dealer enters any quotation which is in violation of

the rule, the Commission will consider the need for prompt enforcement action.

If any broker-dealer or other person has any information which may relate to this matter, they

should contact Jay Scoggins at (303) 844-1105, Kimberly S. Gre